This section includes information on grants and other funding opportunities available from federal government agencies on menopause and related topics. These opportunities include funding for research projects, capacity-building programs, and more.

Agency for Healthcare Research and Quality (AHRQ)

AHRQ Announces Interest in Primary Care Research (Open until February 21, 2025)

This notice solicits grant applications that seek to advance the science of primary care.

Special Emphasis Notice: AHRQ Announces Interest in Health Services Research to Improve Healthcare for Persons Living with Disabilities (Open until November 20, 2025)

This notice solicits grant applications seeking to advance the nation’s goal of improving health outcomes for people living with disabilities through enhanced or innovative care. This includes health services research and interventions to reduce disparities in the quality of care, increase patient safety, improve health care access and effectiveness, and ultimately improve health outcomes for people with disabilities.

Special Emphasis Notice: AHRQ Announces Interest in Health Services Research to Improve Care Delivery, Access, Quality, Equity, and Health Outcomes for Older Adults (Open until May 15, 2027)

This notice solicits grant applications that seek to advance the nation’s goal of improving care delivery, access, quality, equity, and health outcomes for older adults by addressing questions related to the development, implementation, evaluation, and scale of person-centered models of care and thus optimizing the physical and mental health, functional status, and well-being of older adults.

Special Emphasis Notice: AHRQ Announces Interest in Research to Improve Treatment and Management of Menopause Symptoms (open until December 20, 2027)

This Special Emphasis Notice (SEN) informs the research community of the Agency for Healthcare Research and Quality’s (AHRQ) strong and continued interest in receiving health services research grant applications which focus on improving the diagnosis, treatment, and management of perimenopause and menopausal symptoms (i.e., menopause-transition (MT) and menopause-related chronic conditions (such as, but not limited to: osteoporosis, cardiovascular disease, and diabetes) to help improve women's health outcomes.

National Institutes of Health (NIH)

All NIH funding opportunities are available at https://grants.nih.gov. Applicants can search for keywords related to menopause to find the latest grant opportunities. Below are some relevant open funding opportunities.

National Institute on Deafness and Other Communication Disorders (NIDCD)

Notice of Special Interest (NOSI): Encouraging Women’s Health Research within the NIDCD Mission Areas (Open through May 5, 2026)
This notice solicits grant applications seeking to improve women's health across the lifespan within the scope of NIDCD’s mission. The projects may include biological studies incorporating anatomical, structural, hormonal, or genetic aspects; behavioral traits; societal aspects; or health care–related activities that may benefit women’s quality of life.

National Institute on Minority Health and Health Disparities (NIMHD)

Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required) (Open through December 11, 2025)
This funding opportunity seeks applications for multilevel and multidisciplinary intervention research to improve quality of life and promote successful aging across the life course among people with HIV and comorbidities—specifically those who are in underserved racial and ethnic groups and have low socioeconomic status, who are disproportionately affected.

Office of Research on Women’s Health (ORWH)

Notice of Special Interest: Women’s Health Research (Open through November 4, 2027)

This notice seeks applications focused on diseases and conditions that predominantly affect women (e.g., autoimmune diseases, depressive disorders, Alzheimer’s disease, Alzheimer’s disease-related dementias, and being a victim of gender-based violence), present and progress differently in women (e.g., cardiovascular disease, HIV, and reproductive aging and its implications), or are female-specific (e.g., uterine fibroids, endometriosis, and menopause).